Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 50 DMA | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Earnings Movers | Other | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 2.98% | |
Earnings Movers | Other | 2.98% | |
BB Squeeze Ended | Range Expansion | 2.98% | |
Above Upper BB | Strength | 2.98% | |
Gapped Up | Strength | 2.98% |
Alert | Time |
---|---|
Possible Pocket Pivot | about 17 hours ago |
Up 1 ATR | about 19 hours ago |
60 Minute Opening Range Breakout | about 19 hours ago |
50 DMA Resistance | about 20 hours ago |
Up 5% | about 20 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/14/2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.3099 |
52 Week Low | 1.8101 |
Average Volume | 273,022 |
200-Day Moving Average | 3.95 |
50-Day Moving Average | 3.74 |
20-Day Moving Average | 3.34 |
10-Day Moving Average | 3.51 |
Average True Range | 0.23 |
RSI (14) | 60.00 |
ADX | 20.43 |
+DI | 26.42 |
-DI | 15.57 |
Chandelier Exit (Long, 3 ATRs) | 3.22 |
Chandelier Exit (Short, 3 ATRs) | 3.77 |
Upper Bollinger Bands | 3.73 |
Lower Bollinger Band | 2.96 |
Percent B (%b) | 1.09 |
BandWidth | 23.21 |
MACD Line | -0.01 |
MACD Signal Line | -0.08 |
MACD Histogram | 0.0668 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.28 | ||||
Resistance 3 (R3) | 4.27 | 4.09 | 4.20 | ||
Resistance 2 (R2) | 4.09 | 3.97 | 4.10 | 4.17 | |
Resistance 1 (R1) | 3.95 | 3.90 | 4.02 | 3.96 | 4.15 |
Pivot Point | 3.77 | 3.77 | 3.81 | 3.78 | 3.77 |
Support 1 (S1) | 3.63 | 3.65 | 3.70 | 3.64 | 3.45 |
Support 2 (S2) | 3.45 | 3.58 | 3.46 | 3.43 | |
Support 3 (S3) | 3.31 | 3.45 | 3.40 | ||
Support 4 (S4) | 3.32 |